1-3 of 3
Meng-xing Xue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML

Free
Clinical Trials & Observations
Jing Lu, Sheng-li Xue, Ying Wang, Xue-feng He, Xiao-hui Hu, Miao Miao, Yang Zhang, Zai-xiang Tang, Jun-dan Xie, Xiao-fei Yang, Ming-zhu Xu, Yao-yao Shen, Feng Du, Qian Wu, Meng-xing Xue, Yun Wang, Ai-ling Deng, Xue-qing Dou, Yang Xu, Hai-ping Dai, De-pei Wu, Su-ning Chen
Journal: Blood
Blood (2025) 145 (22): 2645–2655.
https://doi.org/10.1182/blood.2024027217
Published: 2025
Includes: Supplemental data
Journal Articles

FLT3 Mutation in Patients with Acute Promyelocytic Leukemia Has No Effect on Therapy Response.

Free
Meng Xing Xue, PhD, Hui Ying Qiu, MD PhD, Yu Feng Feng, MD PhD, Jin Lan Pan, MD PhD, Su Ning Chen, MD PhD, De Pei Wu, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4239.
https://doi.org/10.1182/blood.V110.11.4239.4239
Published: 2007
Journal Articles

The Clinical Features and the Efficient Therapy of 66 Acute Promyelocytic Leukemia Patients with High Initial White Blood Cell Count.

Free
Hui-ying Qiu, MD, PhD, Meng-xing Xue, PhD, Ai-ning Sun, MD, PhD, Yue-jun Liu, MD, PhD, De Pei Wu, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4363.
https://doi.org/10.1182/blood.V110.11.4363.4363
Published: 2007